Characterization of Key Bio-Nano Interactions between Organosilica Nanoparticles and Candida albicans

Vidhishri Kesarwani, Hannah G. Kelly, Madhu Shankar, Kye J. Robinson, Stephen J. Kent, Ana Traven, Simon R. Corrie

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Nanoparticle-cell interactions between silica nanomaterials and mammalian cells have been investigated extensively in the context of drug delivery, diagnostics, and imaging. While there are also opportunities for applications in infectious disease, the interactions of silica nanoparticles with pathogenic microbes are relatively underexplored. To bridge this knowledge gap, here, we investigate the effects of organosilica nanoparticles of different sizes, concentrations, and surface coatings on surface association and viability of the major human fungal pathogen Candida albicans. We show that uncoated and PEGylated organosilica nanoparticles associate with C. albicans in a size and concentration-dependent manner, but on their own, do not elicit antifungal activity. The particles are also shown to associate with human white blood cells, in a similar trend as observed with C. albicans, and remain noncytotoxic toward neutrophils. Smaller particles are shown to have low association with C. albicans in comparison to other sized particles and their association with blood cells was also observed to be minimal. We further demonstrate that by chemically immobilizing the clinically important echinocandin class antifungal drug, caspofungin, to PEGylated nanoparticles, the cell-material interaction changes from benign to antifungal, inhibiting C. albicans growth when provided in high local concentration on a surface. Our study provides the foundation for defining how organosilica particles could be tailored for clinical applications against C. albicans. Possible future developments include designing biomaterials that could detect, prevent, or treat bloodstream C. albicans infections, which at present have very high patient mortality.

Original languageEnglish
Pages (from-to)34676-34687
Number of pages12
JournalACS Applied Materials and Interfaces
Volume11
Issue number38
DOIs
Publication statusPublished - 25 Sep 2019

Keywords

  • blood cells
  • Candida albicans
  • caspofungin
  • cell association
  • cytotoxicity
  • organosilica

Cite this

@article{eab6594cf70747e1adca05c0c6f8c3d1,
title = "Characterization of Key Bio-Nano Interactions between Organosilica Nanoparticles and Candida albicans",
abstract = "Nanoparticle-cell interactions between silica nanomaterials and mammalian cells have been investigated extensively in the context of drug delivery, diagnostics, and imaging. While there are also opportunities for applications in infectious disease, the interactions of silica nanoparticles with pathogenic microbes are relatively underexplored. To bridge this knowledge gap, here, we investigate the effects of organosilica nanoparticles of different sizes, concentrations, and surface coatings on surface association and viability of the major human fungal pathogen Candida albicans. We show that uncoated and PEGylated organosilica nanoparticles associate with C. albicans in a size and concentration-dependent manner, but on their own, do not elicit antifungal activity. The particles are also shown to associate with human white blood cells, in a similar trend as observed with C. albicans, and remain noncytotoxic toward neutrophils. Smaller particles are shown to have low association with C. albicans in comparison to other sized particles and their association with blood cells was also observed to be minimal. We further demonstrate that by chemically immobilizing the clinically important echinocandin class antifungal drug, caspofungin, to PEGylated nanoparticles, the cell-material interaction changes from benign to antifungal, inhibiting C. albicans growth when provided in high local concentration on a surface. Our study provides the foundation for defining how organosilica particles could be tailored for clinical applications against C. albicans. Possible future developments include designing biomaterials that could detect, prevent, or treat bloodstream C. albicans infections, which at present have very high patient mortality.",
keywords = "blood cells, Candida albicans, caspofungin, cell association, cytotoxicity, organosilica",
author = "Vidhishri Kesarwani and Kelly, {Hannah G.} and Madhu Shankar and Robinson, {Kye J.} and Kent, {Stephen J.} and Ana Traven and Corrie, {Simon R.}",
year = "2019",
month = "9",
day = "25",
doi = "10.1021/acsami.9b10853",
language = "English",
volume = "11",
pages = "34676--34687",
journal = "ACS Applied Materials and Interfaces",
issn = "1944-8244",
publisher = "ACS Publications",
number = "38",

}

Characterization of Key Bio-Nano Interactions between Organosilica Nanoparticles and Candida albicans. / Kesarwani, Vidhishri; Kelly, Hannah G.; Shankar, Madhu; Robinson, Kye J.; Kent, Stephen J.; Traven, Ana; Corrie, Simon R.

In: ACS Applied Materials and Interfaces, Vol. 11, No. 38, 25.09.2019, p. 34676-34687.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Characterization of Key Bio-Nano Interactions between Organosilica Nanoparticles and Candida albicans

AU - Kesarwani, Vidhishri

AU - Kelly, Hannah G.

AU - Shankar, Madhu

AU - Robinson, Kye J.

AU - Kent, Stephen J.

AU - Traven, Ana

AU - Corrie, Simon R.

PY - 2019/9/25

Y1 - 2019/9/25

N2 - Nanoparticle-cell interactions between silica nanomaterials and mammalian cells have been investigated extensively in the context of drug delivery, diagnostics, and imaging. While there are also opportunities for applications in infectious disease, the interactions of silica nanoparticles with pathogenic microbes are relatively underexplored. To bridge this knowledge gap, here, we investigate the effects of organosilica nanoparticles of different sizes, concentrations, and surface coatings on surface association and viability of the major human fungal pathogen Candida albicans. We show that uncoated and PEGylated organosilica nanoparticles associate with C. albicans in a size and concentration-dependent manner, but on their own, do not elicit antifungal activity. The particles are also shown to associate with human white blood cells, in a similar trend as observed with C. albicans, and remain noncytotoxic toward neutrophils. Smaller particles are shown to have low association with C. albicans in comparison to other sized particles and their association with blood cells was also observed to be minimal. We further demonstrate that by chemically immobilizing the clinically important echinocandin class antifungal drug, caspofungin, to PEGylated nanoparticles, the cell-material interaction changes from benign to antifungal, inhibiting C. albicans growth when provided in high local concentration on a surface. Our study provides the foundation for defining how organosilica particles could be tailored for clinical applications against C. albicans. Possible future developments include designing biomaterials that could detect, prevent, or treat bloodstream C. albicans infections, which at present have very high patient mortality.

AB - Nanoparticle-cell interactions between silica nanomaterials and mammalian cells have been investigated extensively in the context of drug delivery, diagnostics, and imaging. While there are also opportunities for applications in infectious disease, the interactions of silica nanoparticles with pathogenic microbes are relatively underexplored. To bridge this knowledge gap, here, we investigate the effects of organosilica nanoparticles of different sizes, concentrations, and surface coatings on surface association and viability of the major human fungal pathogen Candida albicans. We show that uncoated and PEGylated organosilica nanoparticles associate with C. albicans in a size and concentration-dependent manner, but on their own, do not elicit antifungal activity. The particles are also shown to associate with human white blood cells, in a similar trend as observed with C. albicans, and remain noncytotoxic toward neutrophils. Smaller particles are shown to have low association with C. albicans in comparison to other sized particles and their association with blood cells was also observed to be minimal. We further demonstrate that by chemically immobilizing the clinically important echinocandin class antifungal drug, caspofungin, to PEGylated nanoparticles, the cell-material interaction changes from benign to antifungal, inhibiting C. albicans growth when provided in high local concentration on a surface. Our study provides the foundation for defining how organosilica particles could be tailored for clinical applications against C. albicans. Possible future developments include designing biomaterials that could detect, prevent, or treat bloodstream C. albicans infections, which at present have very high patient mortality.

KW - blood cells

KW - Candida albicans

KW - caspofungin

KW - cell association

KW - cytotoxicity

KW - organosilica

UR - http://www.scopus.com/inward/record.url?scp=85072686899&partnerID=8YFLogxK

U2 - 10.1021/acsami.9b10853

DO - 10.1021/acsami.9b10853

M3 - Article

VL - 11

SP - 34676

EP - 34687

JO - ACS Applied Materials and Interfaces

JF - ACS Applied Materials and Interfaces

SN - 1944-8244

IS - 38

ER -